- Home
- PULM
PULM
Pulmatrix Inc.
as 11-22-2024 10:38am EST
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | FRAMINGHAM |
| Market Cap: | 7.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.55 - $8.44 | Next Earning Date: | 11-08-2024 |
| Revenue: | $10,005,000 | Revenue Growth: | 47.05% |
| Revenue Growth (this year): | -3.07% | Revenue Growth (next year): | 1.00% |
Latest Pulmatrix Inc. News
PULM Breaking Stock News: Dive into PULM Ticker-Specific Updates for Smart Investing
PR Newswire
9 days ago
Pulmatrix and Cullgen Announce Proposed Merger
Simply Wall St.
12 days ago
Pulmatrix Third Quarter 2024 Earnings: US$0.71 loss per share (vs US$1.03 loss in 3Q 2023)
PR Newswire
14 days ago
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Simply Wall St.
3 months ago
Pulmatrix Second Quarter 2024 Earnings: US$1.59 loss per share (vs US$1.05 loss in 2Q 2023)
PR Newswire
3 months ago
Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Journal-News, Hamilton, Ohio
5 months ago
Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame
Motley Fool
5 months ago
Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now
TechCrunch
5 months ago
Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
Compare PULM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PULM Pulmatrix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.